Last update 20 Mar 2025

Pyridoxal Phosphate Hydrate/Fursultiamine Hydrochloride/ Riboflavin/Hydroxocobalamin Acetate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
VITADAN, VITANEURIN, ビタダン
+ [1]
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases+ [1]
Active Indication
ArthralgiaNeuralgiaNeuritis+ [1]
Inactive Indication-
Originator Organization
Teva Takeda Pharma Ltd.Teva Takeda Pharma Ltd.Startup
Active Organization
Medisa Shinyaku, Inc.Sawai Pharmaceutical Co., Ltd.Sawai Pharmaceutical Co., Ltd.Teva Takeda Pharma Ltd.Teva Takeda Pharma Ltd.Startup
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (01 Feb 1968),
Avitaminosis
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC17H20N4O6
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N
CAS Registry83-88-5
View All Structures (4)

Related

1
Clinical Trials associated with Pyridoxal Phosphate Hydrate/Fursultiamine Hydrochloride/ Riboflavin/Hydroxocobalamin Acetate
JPRN-UMIN000022292
/ CompletedNot ApplicableIIT
Efficacy and safety of hydroxocobalamin acetate in patients with taxane-induced sensory peripheral neuropathy A multi-center, observational study(HAPPY study) - HAPPY study
100 Clinical Results associated with Pyridoxal Phosphate Hydrate/Fursultiamine Hydrochloride/ Riboflavin/Hydroxocobalamin Acetate
Login to view more data
100 Translational Medicine associated with Pyridoxal Phosphate Hydrate/Fursultiamine Hydrochloride/ Riboflavin/Hydroxocobalamin Acetate
Login to view more data
100 Patents (Medical) associated with Pyridoxal Phosphate Hydrate/Fursultiamine Hydrochloride/ Riboflavin/Hydroxocobalamin Acetate
Login to view more data
100 Deals associated with Pyridoxal Phosphate Hydrate/Fursultiamine Hydrochloride/ Riboflavin/Hydroxocobalamin Acetate
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Arthralgia
Japan
Medisa Shinyaku, Inc.
04 Mar 1994
Neuralgia
Japan
Medisa Shinyaku, Inc.
04 Mar 1994
Neuritis
Japan
Medisa Shinyaku, Inc.
04 Mar 1994
Avitaminosis
Japan
Sawai Pharmaceutical Co., Ltd.Sawai Pharmaceutical Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free